iBio (IBIO) Current Leases (2016 - 2026)
iBio (IBIO) posted quarterly Current Leases of $532000.0 for Q1 2026, up 11.76% year-over-year from $476000.0 in Q1 2025, and up 2.7% quarter-over-quarter from $518000.0 in Q4 2025.
iBio (IBIO) Current Leases (2016 - 2026) Analysis & Trends
iBio (IBIO) has reported Current Leases for 11 consecutive years, with $532000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases rose 11.76% year-over-year to $532000.0; the TTM figure through Mar 2026 stood at $532000.0 (up 11.76% YoY), while the FY2025 annual figure was $490000.0, up 63.88% from the prior year.
- Current Leases rose to $532000.0 in Q1 2026 per IBIO's latest filing, from $518000.0 in the prior quarter.
- Across five years, Current Leases topped out at $532000.0 in Q1 2026 and bottomed at $10000.0 in Q1 2022.
- Historically, Current Leases has averaged $336294.1 across 5 years, with a median of $299000.0 in 2023.
- Annual changes were most pronounced in 2022 — Current Leases plunged 96.86% — and 2023, when it surged 2550.0%.
- iBio's Current Leases stood at $259000.0 in 2022, then jumped by 59.07% to $412000.0 in 2023, then slumped by 50.24% to $205000.0 in 2024, then surged by 152.68% to $518000.0 in 2025, then grew by 2.7% to $532000.0 in 2026.
- Business Quant data shows IBIO's Current Leases at $532000.0 in Q1 2026, $518000.0 in Q4 2025, and $504000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.79 Bn | 131.94 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.74 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.32 Bn | 54.18 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.81 Bn | 28.50 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.56 Bn | 26.40 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | - |
| 10 | iBio | 174.02 Mn | 174.02 Mn | - | 532,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 532,000.00 |
| Dec 31, 2025 | 518,000.00 |
| Sep 30, 2025 | 504,000.00 |
| Jun 30, 2025 | 490,000.00 |
| Mar 31, 2025 | 476,000.00 |
| Dec 31, 2024 | 205,000.00 |
| Sep 30, 2024 | 490,000.00 |
| Jun 30, 2024 | 299,000.00 |
| Mar 31, 2024 | 292,000.00 |
| Dec 31, 2023 | 412,000.00 |
| Sep 30, 2023 | 299,000.00 |
| Jun 30, 2023 | 272,000.00 |
| Mar 31, 2023 | 265,000.00 |
| Dec 31, 2022 | 259,000.00 |
| Sep 30, 2022 | 303,000.00 |
| Jun 30, 2022 | 91,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Dec 31, 2021 | 45,000.00 |
| Sep 30, 2021 | 374,000.00 |
| Jun 30, 2021 | 367,000.00 |